US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 35.820
  • -0.300-0.83%
Close Nov 21 16:00 ET
  • 35.820
  • 0.0000.00%
Post 16:20 ET
1.98BMarket Cap33.57P/E (TTM)

About Supernus Pharmaceuticals Company

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

Company Profile

SymbolSUPN
Company NameSupernus Pharmaceuticals
Listing DateMay 1, 2012
Issue Price5.00
Founded2005
CEOMr. Jack A. Khattar
MarketNASDAQ
Employees652
Fiscal Year Ends12-31
Address9715 Key West Avenue
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-301-838-2500
Websitehttp://www.supernus.com

Company Executives

  • Name
  • Position
  • Salary
  • Jack A. Khattar
  • Director, President, Chief Executive Officer and Secretary
  • 13.28M
  • Dr. Jonathan Rubin, M.B.A.,M.D.
  • Senior Vice President, Research and Development and Chief Medical Officer
  • 1.59M
  • Timothy C. Dec
  • Senior Vice President, Principal Accounting Officer and Chief Financial Officer
  • 2.38M
  • Padmanabh P. Bhatt
  • Senior Vice President, Intellectual Property and Chief Scientific Officer
  • 1.47M
  • Tami Tillotson Martin, Esq.,R.N.
  • Senior Vice President, Regulatory Affairs
  • --
  • Frank Mottola
  • Senior Vice President, Quality, GMP Operations and Information Technology
  • 1.79M
  • Charles W. Newhall, III
  • Chairman of the Board
  • 407.02K
  • Bethany Sensenig
  • Independent Director
  • 514.39K
  • Dr. Georges Gemayel,PhD
  • Independent Director
  • 378.52K
  • Frederick M. Hudson
  • Independent Director
  • 385.02K
  • Dr. Carrolee Barlow, M.D.,PhD
  • Independent Director
  • 376.02K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data